Mark Harbinson

2.1k total citations
71 papers, 1.3k citations indexed

About

Mark Harbinson is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Mark Harbinson has authored 71 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 31 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Surgery. Recurrent topics in Mark Harbinson's work include Cardiac Imaging and Diagnostics (22 papers), Acute Myocardial Infarction Research (8 papers) and Cardiac electrophysiology and arrhythmias (7 papers). Mark Harbinson is often cited by papers focused on Cardiac Imaging and Diagnostics (22 papers), Acute Myocardial Infarction Research (8 papers) and Cardiac electrophysiology and arrhythmias (7 papers). Mark Harbinson collaborates with scholars based in United Kingdom, Slovakia and United States. Mark Harbinson's co-authors include S. Richard Underwood, Constantinos Anagnostopoulos, Andrew Kelion, Elizabeth Prvulovich, A. C. Tweddel, Abdallah Al‐Mohammad, M. Cerqueira, Emlyn Flint, Peter J. Ell and Leslee J. Shaw and has published in prestigious journals such as Journal of the American College of Cardiology, The Journal of Physiology and European Heart Journal.

In The Last Decade

Mark Harbinson

68 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Harbinson United Kingdom 19 604 564 218 181 132 71 1.3k
Theo E. Meyer United States 21 522 0.9× 1.6k 2.8× 110 0.5× 399 2.2× 105 0.8× 58 1.9k
Jayanth R. Arnold United Kingdom 24 736 1.2× 1.2k 2.2× 123 0.6× 481 2.7× 170 1.3× 83 1.9k
Anders Junker Denmark 18 434 0.7× 714 1.3× 175 0.8× 977 5.4× 154 1.2× 69 1.8k
Costantino Costantini Brazil 18 653 1.1× 1.2k 2.1× 71 0.3× 601 3.3× 95 0.7× 63 1.7k
Boaz D. Rosen United States 27 1.4k 2.3× 2.4k 4.2× 178 0.8× 446 2.5× 211 1.6× 57 2.9k
John U. Doherty United States 21 476 0.8× 1.6k 2.9× 132 0.6× 425 2.3× 100 0.8× 38 2.1k
Michelle J. Kupka United States 5 318 0.5× 1.7k 2.9× 144 0.7× 421 2.3× 210 1.6× 6 2.2k
Giuseppe Barletta Italy 28 371 0.6× 1.2k 2.1× 260 1.2× 801 4.4× 400 3.0× 128 2.2k
Sanjay Divakaran United States 21 322 0.5× 602 1.1× 78 0.4× 289 1.6× 162 1.2× 78 1.2k
Dilek Ural Türkiye 21 211 0.3× 898 1.6× 65 0.3× 275 1.5× 249 1.9× 146 1.6k

Countries citing papers authored by Mark Harbinson

Since Specialization
Citations

This map shows the geographic impact of Mark Harbinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Harbinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Harbinson more than expected).

Fields of papers citing papers by Mark Harbinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Harbinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Harbinson. The network helps show where Mark Harbinson may publish in the future.

Co-authorship network of co-authors of Mark Harbinson

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Harbinson. A scholar is included among the top collaborators of Mark Harbinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Harbinson. Mark Harbinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hill, Loreena, et al.. (2023). Risk and Management of Patients with Cancer and Heart Disease. Cardiology and Therapy. 12(2). 227–241. 1 indexed citations
3.
Walls, Gerard, John D. O’Connor, Mark Harbinson, et al.. (2023). Association between statin therapy dose intensity and radiation cardiotoxicity in non-small cell lung cancer: Results from the NI-HEART study. Radiotherapy and Oncology. 186. 109762–109762. 12 indexed citations
4.
O’Neill, Ciarán, David Donnelly, Mark Harbinson, et al.. (2022). Survival of cancer patients with pre-existing heart disease. BMC Cancer. 22(1). 847–847. 9 indexed citations
5.
Maxwell, Alexander P., et al.. (2019). Serum amyloid A levels are associated with polymorphic variants in the serum amyloid A 1 and 2 genes. Irish Journal of Medical Science (1971 -). 188(4). 1175–1183. 6 indexed citations
6.
Connolly, Michael, David McEneaney, Ian Menown, Neal Morgan, & Mark Harbinson. (2015). Novel Biomarkers of Acute Kidney Injury After Contrast Coronary Angiography. Cardiology in Review. 23(5). 240–246. 20 indexed citations
8.
Bleakley, Caroline, et al.. (2015). Ultrasound entropy may be a new non-invasive measure of pre-clinical vascular damage in young hypertensive patients. Cardiovascular Ultrasound. 13(1). 12–12. 4 indexed citations
9.
McKinley, Michelle C., Mark Harbinson, R Noad, et al.. (2014). The Effect of Multiple Micronutrient Supplementation on Left Ventricular Ejection Fraction in Patients With Chronic Stable Heart Failure. JACC Heart Failure. 2(3). 308–317. 28 indexed citations
10.
Holmes, David, Malcolm Campbell, Mark Harbinson, & David Bell. (2013). Protective Effects of Intermedin On Cardiovascular, Pulmonary and Renal Diseases: Comparison with Adrenomedullin and CGRP. Current Protein and Peptide Science. 14(4). 294–329. 34 indexed citations
11.
McKinley, Michelle C., et al.. (2012). The Role of Micronutrients in Heart Failure. Journal of the Academy of Nutrition and Dietetics. 112(6). 870–886. 60 indexed citations
12.
Bleakley, Caroline, et al.. (2012). Lifetime Risk of Cardiovascular Disease: The Next Generation in Risk Prediction. Canadian Journal of Cardiology. 29(2). 147–150. 4 indexed citations
13.
Bell, David, et al.. (2011). AM1‐receptor‐dependent protection by intermedin of human vascular and cardiac non‐vascular cells from ischaemia–reperfusion injury. The Journal of Physiology. 590(5). 1181–1197. 15 indexed citations
14.
15.
Harbinson, Mark, et al.. (2010). Myocardial wall motion and thickening assessment in early gated SPECT images of acute coronary syndrome patients likely to have inferolateral perfusion defects. International journal of cardiac imaging. 26(8). 881–891. 2 indexed citations
16.
Neill, John D., et al.. (2006). ST elevation in lead aVR during exercise testing should not be ignored. PubMed Central. 75(3). 233–234.
17.
Muir, Alison, et al.. (2006). ST segment elevation in lead aVR during exercise testing is associated with LAD stenosis. European Journal of Nuclear Medicine and Molecular Imaging. 34(3). 338–345. 11 indexed citations
18.
Kelion, Andrew, Constantinos Anagnostopoulos, Mark Harbinson, S. Richard Underwood, & M Metcalfe. (2005). Myocardial perfusion scintigraphy in the UK: insights from the British Nuclear Cardiology Society Survey 2000. Heart. 91(suppl 4). iv2–iv5. 19 indexed citations
19.
Anagnostopoulos, Christos‐Nikolaos, Mark Harbinson, Andrew Kelion, et al.. (2003). Procedure guidelines for radionuclide myocardial perfusion imaging.. PubMed. 24(10). 1105–19. 22 indexed citations
20.
Harbinson, Mark, JD Allen, & A.A.J. Adgey. (2000). The effects of potassium-ATP channel modulation on ventricular fibrillation and defibrillation in the pig heart. International Journal of Cardiology. 76(2-3). 187–197. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026